Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

500
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
500
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

275
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
275
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

246
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
246

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

ADAR1 Regulates Alternative Splicing Through an RNA Editing-Independent Mechanism.

International journal of molecular sciences·2026
Same author

Cross-cultural adaptation of the Four Habits Coding Scheme into Danish: a study of inter- and intra-rater reliability in face-to-face and video consultations.

BMC medical education·2026
Same author

Understanding the diagnostic process of endometriosis in primary care: An interview study with general practitioners in Denmark using clinical vignettes.

The European journal of general practice·2026
Same author

The READI European project: Enhancing inclusivity in clinical research.

European journal of clinical investigation·2025
Same author

Historical Perspectives on Scrofula: Competing Medical Discourses and Public Health Implications at the Turn of the 20<sup>th</sup> Century.

Journal of preventive medicine and hygiene·2025
Same author

The burden of endometriosis on quality of life in Danish women: an analysis of the Danish Blood Donor Study.

BMC medicine·2025

関連する実験動画

Updated: Feb 23, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

包摂を超えて,臨床試験は正しい問題を解決しているのか?

Ulrik Bak Kirk1,2, Nikoletta Georgiou3, Ron Hillel4

  • 1Department of Public Health, Aarhus University, Aarhus, 8000, Denmark. ubk@ph.au.dk.

Trials
|February 21, 2026
PubMed
まとめ

デンマークは欧州連合 (EU) の臨床試験を主導しているが,利益のある分野に焦点を当てた研究は,脆弱な集団を無視している. 真のイノベーションには,公平な健康研究と知識生成のための包括的な戦略が必要です.

キーワード:
臨床試験 臨床試験についてエピステミックな不正義イクティブ・キャピタルは,インクルーシビリティは,インクルーシビリティです.革新的保健医療についてパブリック・プライベートのパートナーシップサービスが不足し,代表が不足している人口です.

さらに関連する動画

Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.4K
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.6K

関連する実験動画

Last Updated: Feb 23, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.4K
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.6K

科学分野:

  • 臨床研究の倫理について
  • 保健医療の公平性について
  • 臨床試験におけるイノベーション

背景:

  • デンマークは1人当たりの臨床試験でEUをリードし,イノベーションと業界の魅力を示しています.
  • 臨床試験の量だけでは,研究価値のための不十分なメトリックであり,格差を隠しています.
  • 研究は,腫瘍学やアルツハイマー病などの商業的に実行可能な分野に不釣り合いに集中しています.

研究 の 目的:

  • 臨床試験の量にのみ焦点を当てることの限界を批判的に検討する.
  • 研究において特定の集団を無視する構造的・認識的不公正を強調する.
  • 欧州の臨床研究におけるインクルーシブ・イノベーションの促進のための戦略を探求する.

主な方法:

  • デンマークの臨床研究環境のケーススタディ分析.
  • 臨床試験への含有に関する欧州および国際的議論のレビュー.
  • 現在の包摂戦略が知識生産に及ぼす影響に関する解説.

主要な成果:

  • 有利な分野での臨床試験の集中は,子供,妊婦,高齢者,慢性疾患または利益の少ない状態の人々を無視します.
  • 包摂戦略では,知識生産における真の正義よりも,しばしば数値的表現を優先する.
  • 既存の枠組みは,研究の優先順位付けにおける構造的,認識的不公正を永続させる危険性があります.

結論:

  • チェックリストの含有を超越することは,臨床研究における正義を達成するために不可欠です.
  • 公平な参加と知識の生成は,患者,研究者,社会に利益をもたらします.
  • 欧州の臨床研究エコシステムの中で,より包括的で正義志向的なアプローチを開発する機会があります.